- Home
- HMY vs NBIX Comparison
HMY vs NBIX Comparison
Compare HMY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMY
- NBIX
- Stock Information
- Founded
- HMY 1950
- NBIX 1992
- Country
- HMY South Africa
- NBIX United States
- Employees
- HMY N/A
- NBIX N/A
- Industry
- HMY Precious Metals
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HMY Basic Materials
- NBIX Health Care
- Exchange
- HMY Nasdaq
- NBIX Nasdaq
- Market Cap
- HMY 12.4B
- NBIX 14.4B
- IPO Year
- HMY N/A
- NBIX 1996
- Fundamental
- Price
- HMY $20.17
- NBIX $141.18
- Analyst Decision
- HMY Buy
- NBIX Strong Buy
- Analyst Count
- HMY 3
- NBIX 17
- Target Price
- HMY $12.20
- NBIX $164.94
- AVG Volume (30 Days)
- HMY 5.8M
- NBIX 846.8K
- Earning Date
- HMY 02-04-2016
- NBIX 10-28-2025
- Dividend Yield
- HMY 0.84%
- NBIX N/A
- EPS Growth
- HMY 67.74
- NBIX 2.97
- EPS
- HMY 1.29
- NBIX 3.39
- Revenue
- HMY $4,161,584,110.00
- NBIX $2,509,900,000.00
- Revenue This Year
- HMY $24.20
- NBIX $20.79
- Revenue Next Year
- HMY $3.08
- NBIX $14.73
- P/E Ratio
- HMY $15.40
- NBIX $41.31
- Revenue Growth
- HMY 20.39
- NBIX 18.42
- 52 Week Low
- HMY $7.97
- NBIX $84.23
- 52 Week High
- HMY $22.25
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- HMY 62.19
- NBIX 56.17
- Support Level
- HMY $19.53
- NBIX $136.71
- Resistance Level
- HMY $22.25
- NBIX $140.73
- Average True Range (ATR)
- HMY 0.81
- NBIX 3.35
- MACD
- HMY 0.19
- NBIX -0.11
- Stochastic Oscillator
- HMY 60.97
- NBIX 79.87
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.